A Reference‐Scaled Average Bioequivalence Study of Azithromycin Tablets Manufactured in China and the United States: An Open‐Label, Randomized, Single‐Dose, 3‐Way Crossover Study in Healthy Chinese Subjects Under Fasted and Fed Conditions - Ge, Beikang; Li, Cuiyun; Wei, Hua; Ding, Yanhua; Wu, Min; Liu, Yuwang; Zhang, Kaiting; Peng, Ao (Clinical pharmacology in drug development, 2022)
Keywords: Anti-Bacterial Agents - adverse effects; Antibiotics; Area Under Curve; AUC; azithromycin; Azithromycin - adverse effects; Bioequivalence; China; Cmax; Cross-Over Studies; Humans; pharmacokinetics; Tablets; Therapeutic Equivalency; United States; United States; China; United States--US; pharmacokinetics; Cmax; azithromycin; bioequivalence; AUC